Table 4 Mixed model regression: symptom (subscales) T-scores on premature HCV treatment discontinuation due to side effects or loss to follow-up
Factor (Reference: all others) | T-score, all symptoms B (95% CI) | T-score, somatic B (95% CI) | T-score, sleep B (95% CI) | T-score, neuropsyp. B (95% CI) |
|---|---|---|---|---|
Non-completer, AE/side effects | 7.33 (1.05, 13.61)* | 7.46 (0.70, 14.22)* | 3.72 (−0.67, 8.10) | 6.28 (1.31, 11.24)* |
Constant | 48.85 (47.03, 50.68)*** | 48.90 (47.12, 50.68)*** | 49.53 (47.85, 51.20)*** | 49.06 (47.24, 50.87)*** |
No. of patients | 103 | 103 | 103 | 103 |
ICC | 0.6 | 0.59 | 0.57 | 0.58 |